miR-133b Regulation of Connective Tissue Growth Factor: A Novel Mechanism in Liver Pathology

Altin Gjymishka1, Liya Pi1, Seh-Hoon Oh1

  • 1Department of Pediatrics, University of Florida, Gainesville, Florida.

Insights

MicroRNA-133b (miR-133b) suppresses hepatocellular carcinoma (HCC) cell growth and migration by downregulating connective tissue growth factor (CTGF). This finding is crucial for understanding liver regeneration and HCC progression.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • MicroRNAs (miRNAs) play roles in liver regeneration and are dysregulated in hepatocellular carcinoma (HCC).
  • Connective tissue growth factor (CTGF) is a direct target of miR-133b and is vital for the ductular reaction (DR)/oval cell (OC) response during liver injury.
  • Hepatocyte proliferation can be inhibited by hepatotoxins, necessitating alternative mechanisms for liver repair.

Purpose of the Study:

  • To investigate the influence of miR-133b's regulation of CTGF on HCC cell proliferation and migration.
  • To determine the role of miR-133b and CTGF in the ductular reaction/oval cell response.

Main Methods:

  • Analysis of miR-133b expression in HCC patient samples and a rat liver injury model.
  • In vitro studies using adenoviral systems to overexpress miR-133b in HepG2 HCC cells and WBF-344 rat OCs.
  • In vivo studies involving miR-133b overexpression in rat and mouse models of liver injury and regeneration.

Main Results:

  • miR-133b was found to be downregulated in HCC samples and induced during rat DR/OC activation.
  • Overexpression of miR-133b in vitro decreased CTGF expression, HCC cell proliferation, and migration, as well as OC proliferation.
  • In vivo overexpression of miR-133b led to CTGF downregulation and reduced OC proliferation in liver injury models.

Conclusions:

  • miR-133b acts as a tumor suppressor in HCC by inhibiting proliferation and migration.
  • The miR-133b-CTGF axis is a critical regulator of both HCC progression and the ductular reaction/oval cell response in liver regeneration.
  • Targeting miR-133b may offer a therapeutic strategy for hepatocellular carcinoma and liver injury.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K